EBR Systems (ASX:EBR) Completes First US Commercial Implants of WiSE CRT System
EBR Systems (ASX:EBR) completes first US commercial implants of its WiSE CRT System, advancing towards market release and reimbursement in October 2025.
Category: ASX-EBR
EBR Systems
EBR Systems (ASX:EBR) Secures NTAP Reimbursement Approval
EBR Systems (ASX:EBR) proposes CMS approval of NTAP reimbursement for its WiSE CRT System, advancing US market strategy.
EBR Systems (ASX:EBR) Advances Leadless Pacemaker Technology with Successful Trials
EBR Systems (ASX:EBR) reports successful SOLVE-CRT trials and outlines a clear FDA approval pathway for its innovative leadless pacemaker system.